Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Pfizer Stock: Is PFE Underperforming the Healthcare Sector?

With a market cap of $144.8 billion, New York-based Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, develops, and markets innovative medicines and vaccines across diverse therapeutic areas. With a streamlined portfolio post divestitures, it focuses on groundbreaking treatments in oncology, immunology, rare diseases, and infectious diseases.

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Pfizer fits this criterion perfectly. Pfizer stands out in the market with its innovative pipeline of cutting-edge medicines and vaccines, including advancements in mRNA technology like Comirnaty and Paxlovid, and its focus on addressing unmet medical needs across diverse therapeutic areas. Additionally, its patient-centric initiatives, such as the PfizerForAll platform and partnerships to bridge healthcare disparities, emphasize accessible and equitable care.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.